• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Raptor Pharmaceuticals Corp. (RPTP)

    -NasdaqGM
    10.81 Up 0.10(0.93%) Apr 24, 4:00PM EDT
    |After Hours : 10.88 Up 0.07 (0.68%) Apr 24, 4:10PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 17,286   23,764   16,313   12,134  
    Cost of Revenue3,190  3,917  995  1,314  
    Gross Profit 14,096   19,847   15,318   10,820  
    Operating Expenses
    Research Development13,852  9,001  11,077  9,547  
    Selling General and Administrative16,186  15,078  13,326  12,064  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (15,942) (4,232) (9,085) (10,791)
    Income from Continuing Operations
    Total Other Income/Expenses Net184  2,571  (105)(1,115)
    Earnings Before Interest And Taxes(15,758)(1,661)(9,190)(11,906)
    Interest Expense3,115  4,380  3,497  2,979  
    Income Before Tax(18,873)(6,041)(12,687)(14,885)
    Income Tax Expense50  (8)6  6  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(18,923)(6,033)(12,693)(14,891)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (18,923) (6,033) (12,693) (14,891)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (18,923) (6,033) (12,693) (14,891)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.